Chronic active hepatitis in transgenic mice expressing interferon-gamma in the liver
about
Liver-directed gamma interferon gene delivery in chronic hepatitis C.Liver infiltrating T lymphocytes express interferon gamma and inducible nitric oxide synthase in chronic hepatitis C virus infectionHLA class I-restricted cytotoxic T lymphocytes specific for hepatitis C virus. Identification of multiple epitopes and characterization of patterns of cytokine releaseFatal propionic acidemia in mice lacking propionyl-CoA carboxylase and its rescue by postnatal, liver-specific supplementation via a transgeneTransgenic mice aberrantly expressing pyruvate dehydrogenase complex E2 component on biliary epithelial cells do not show primary biliary cirrhosis.Association between chronic liver and colon inflammation during the development of murine syngeneic graft-versus-host diseaseDivergent role of gamma interferon in a murine model of pulmonary versus systemic Klebsiella pneumoniae infectionActivation of stem cells in hepatic diseases.Natural killer cells mediate severe liver injury in a murine model of halothane hepatitisMedullary thymic epithelial cells and central tolerance in autoimmune hepatitis development: novel perspective from a new mouse model.Activation of IFN-γ/STAT/IRF-1 in hepatic responses to Klebsiella pneumoniae infectionCysteine 10 is a key residue in amyloidogenesis of human transthyretin Val30Met.Intrahepatic natural immunity and HCV immunopathogenesis.IFN-γ inhibits gastric carcinogenesis by inducing epithelial cell autophagy and T-cell apoptosisModulation of the gene network connected to interferon-gamma in liver regeneration from oval cells.Review of cytokine profiles in patients with hepatitisInterferon-gamma induces chronic active myocarditis and cardiomyopathy in transgenic mice.Ectopic expression of N-acetylglucosaminyltransferase III in transgenic hepatocytes disrupts apolipoprotein B secretion and induces aberrant cellular morphology with lipid storage.Liver degeneration and lymphoid deficiencies in mice lacking suppressor of cytokine signaling-1.Functional skewing of the global CD8 T cell population in chronic hepatitis B virus infection.Hypothyroidism in transgenic mice expressing IFN-gamma in the thyroidCutting edge: chronic inflammatory liver disease in mice expressing a CD28-specific ligand.Protein tyrosine phosphatases PTP-1B and TC-PTP play nonredundant roles in macrophage development and IFN-gamma signaling.Interferon-gamma-mediated activation of STAT1alpha regulates growth factor-induced mitogenesis.End-organ damage in a mouse model of fulminant liver inflammation requires CD4+ T cell production of IFN-gamma but is independent of Fas.Role of major histocompatibility complex class II expression by non-hematopoietic cells in autoimmune and inflammatory disorders: facts and fiction.HCV-induced regulatory alterations of IL-1β, IL-6, TNF-α, and IFN-ϒ operative, leading liver en-route to non-alcoholic steatohepatitis.Transient Expression of Transgenic IL-12 in Mouse Liver Triggers Unremitting Inflammation Mimicking Human Autoimmune Hepatitis.Hepatitis C virus core protein differently regulates the JAK-STAT signaling pathway under interleukin-6 and interferon-gamma stimuli.Chronic liver inflammation dominated by interferon-γ can prevent hepatocarcinogenesisInterleukin-30: a novel antiinflammatory cytokine candidate for prevention and treatment of inflammatory cytokine-induced liver injuryVariable Resistance of RMS to Interferon γ SignalingInterferon-gamma directly mediates developmental biliary defectsAnti-Inflammatory Activity Is a Possible Mechanism by Which the Polyherbal Formulation Comprised of Nigella sativa (Seeds), Hemidesmus indicus (Root), and Smilax glabra (Rhizome) Mediates Its Antihepatocarcinogenic EffectsAn in vitro bioassay for xenobiotics using the SXR-driven human CYP3A4/lacZ reporter gene.The role of intrahepatic gammadelta-T cells for liver injury induced by Salmonella infection in mouse.STAT1 plays an essential role in LPS/D-galactosamine-induced liver apoptosis and injury.IFNgamma expression inhibits LHBs storage disease and ground glass hepatocyte appearance, but exacerbates inflammation and apoptosis in HBV surface protein-accumulating transgenic livers.Interferon-gamma-mediated hepatocarcinogenesis in mice treated with diethylnitrosamine.Tryptophan protects hepatocytes against reactive oxygen species-dependent cell death via multiple pathways including Nrf2-dependent gene induction.
P2860
Q27472673-3C0600AC-A410-4EC7-B33A-0487113E8CAEQ27477843-B57C5F5E-EFBF-4BB4-8A02-A24A79059E13Q27478341-07FA7FE4-2046-45E1-B6D3-0B4B08E00A8FQ28594405-D3156B27-08B4-4B03-9F94-702BA882B806Q33247599-10F0BC6E-9837-4A4C-9700-E940996ECC6AQ34178879-71275CDD-A9C0-4AE0-B0F6-7091341DC915Q34183472-7A1E1A7E-A6FE-4A43-8532-91A0F60B84E9Q34554113-A248A763-CBE7-4277-955A-F5141D1CD673Q34701790-032B1ABA-708C-4311-AEC4-006C8B51F933Q35016702-CE754EF0-70D7-46BA-9F97-9319BA9970C9Q35040365-D4ADBC9B-2897-49B8-B06A-6D0C06CE9631Q35083244-8D8778C0-45CA-464E-B3C8-F8C55B646490Q35091443-29387242-0449-4495-B1D1-AA4470A4DEF7Q35116625-5EBA30F8-8691-40F4-AA82-6C681411398BQ35788200-0887A616-AEA9-4C1F-B399-E31F72B9B516Q35799633-2235D927-5A3D-4309-8865-158DD4003207Q35915997-3C7E8AEA-A0A8-4D1B-92DA-6F14FD581F97Q35925263-5CCF3C19-2BD1-44B4-BA7F-3E44A345FEDCQ36735213-503D2946-DAC1-48C9-8EA2-17F3A3376425Q36853435-21C186A5-4021-47B4-B9B1-C6964C06C22DQ37114935-363B9446-3AD3-49CD-AABB-B9DA0F2B1D02Q37135360-50C0D6CA-1D29-4481-B8FB-BD6B6C0A952CQ37224188-ACD085B8-F2A2-47C6-B814-23577391A16DQ37359399-50553AB0-D239-4F8C-B0C0-B219773CF763Q37393099-EA452F9F-AF3B-4C90-9BBE-2F50C08C7661Q38112727-065D9F05-F9B9-42F3-9F0B-EC7BE3B1D37DQ39174701-8585648F-73F7-447B-BB77-30F31B57FADAQ40627074-3D60717F-D170-4892-8D73-0AFAEFE901F0Q40645437-0BE96750-F878-4168-9899-0D63B36098A3Q41809760-BC18C7A0-7D8D-488E-8E66-D9677985C0E7Q42007477-64609CC1-656E-4D77-A5A8-F961BBFF36F5Q42093148-0B363AAC-D05D-4B4B-B972-31E347E979CDQ42123646-37D4E53D-C606-4818-A3E1-FB892A69A58BQ42397962-D7F8968F-3276-4319-A571-21040FB33FECQ42799626-211C12D4-A3F5-4F33-9117-D0CE844B234BQ43984219-3808BD57-03C8-49F2-A20F-0D6CA38A4A4AQ44484446-69B50364-410B-4446-A779-2162ADDC0B8BQ45862270-FAEE54EF-9FCF-418F-B483-11185BF69F15Q46375786-962A3294-C96B-4DFB-8082-CA22015DB5E8Q46607203-5229BE01-EFBE-47ED-BF8E-55B969772F2D
P2860
Chronic active hepatitis in transgenic mice expressing interferon-gamma in the liver
description
1994 nî lūn-bûn
@nan
1994 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
1994 թվականի հունվարին հրատարակված գիտական հոդված
@hy
1994年の論文
@ja
1994年論文
@yue
1994年論文
@zh-hant
1994年論文
@zh-hk
1994年論文
@zh-mo
1994年論文
@zh-tw
1994年论文
@wuu
name
Chronic active hepatitis in transgenic mice expressing interferon-gamma in the liver
@ast
Chronic active hepatitis in transgenic mice expressing interferon-gamma in the liver
@en
Chronic active hepatitis in transgenic mice expressing interferon-gamma in the liver
@nl
type
label
Chronic active hepatitis in transgenic mice expressing interferon-gamma in the liver
@ast
Chronic active hepatitis in transgenic mice expressing interferon-gamma in the liver
@en
Chronic active hepatitis in transgenic mice expressing interferon-gamma in the liver
@nl
prefLabel
Chronic active hepatitis in transgenic mice expressing interferon-gamma in the liver
@ast
Chronic active hepatitis in transgenic mice expressing interferon-gamma in the liver
@en
Chronic active hepatitis in transgenic mice expressing interferon-gamma in the liver
@nl
P2093
P2860
P356
P1476
Chronic active hepatitis in transgenic mice expressing interferon-gamma in the liver
@en
P2093
Shichiri M
Toyonaga T
Wakasugi S
Yamamura K
P2860
P304
P356
10.1073/PNAS.91.2.614
P407
P577
1994-01-01T00:00:00Z